{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:07:45Z","timestamp":1760854065945,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.nucmedbio.2019.07.006","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T19:20:05Z","timestamp":1562959205000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C]cholylsarcosine"],"prefix":"10.1016","volume":"72-73","author":[{"given":"Kim","family":"Frisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"Kj\u00e6rgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Horsager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Christina","family":"Schacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Lajord","family":"Munk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0005","series-title":"Functional molecular imaging in hepatology","first-page":"49","article-title":"Biliary secretion","author":"Frisch","year":"2012"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0010","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.R049437","article-title":"Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades","volume":"55","author":"Hofmann","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0015","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0025","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.2741\/3399","article-title":"The enterohepatic circulation of bile acids in mammals: form and functions","volume":"14","author":"Hofmann","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"F1000 Faculty Rev","key":"10.1016\/j.nucmedbio.2019.07.006_bb0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.12688\/f1000research.8012.1","article-title":"Recent advances in understanding and managing cholestasis","volume":"5","author":"Wagner","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0035-1571274","article-title":"New therapeutic strategies for primary sclerosing cholangitis","volume":"36","author":"Williamson","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.11.010","article-title":"Mechanisms of cholestasis","volume":"12","author":"Zollner","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0045","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2967\/jnumed.111.098731","article-title":"[N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET\/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs","volume":"53","author":"Frisch","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0050","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2967\/jnumed.115.171579","article-title":"Hepatobiliary secretion kinetics of conjugated bile acids measured in pigs by 11C-cholylsarcosine PET","volume":"57","author":"S\u00f8rensen","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhep.2017.02.023","article-title":"Hepatobiliary transport kinetics of the conjugated bile acid tracer 11C-CSar quantified in healthy humans and patients by positron emission tomography","volume":"67","author":"\u00d8rntoft","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0060","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2017.11.016","article-title":"Functional assessment of hepatobiliary secretion by 11C-cholylsarcosine positron emission tomography","volume":"1864","author":"\u00d8rntoft","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0065","first-page":"260","article-title":"Liver: PET for bile transport kinetics","volume":"14","author":"Dickson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0070","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1021\/acs.molpharmaceut.5b00059","article-title":"PET tracers to study clinically relevant hepatic transporters","volume":"12","author":"Testa","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0075","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/dmd.113.055707","article-title":"The role of organic anion transporters in diagnosing liver diseases by magnetic resonance imaging","volume":"42","author":"Pastor","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1055\/s-0035-1553306","article-title":"Imaging-based Liver function tests \u2013 past, present and future","volume":"187","author":"Geisel","year":"2015","journal-title":"Fortschr R\u00f6ntgenstr"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0016-5085(94)94899-2","article-title":"Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid","volume":"106","author":"Jazrawi","year":"1994","journal-title":"Gastroenterology"},{"issue":"117","key":"10.1016\/j.nucmedbio.2019.07.006_bb0090","doi-asserted-by":"crossref","DOI":"10.3791\/54597","article-title":"Using multi-fluorinated bile acids and in vivo magnetic resonance imaging to measure bile acid transport","author":"Felton","year":"2016","journal-title":"J Vis Exp"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0095","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2967\/jnumed.115.161711","article-title":"Radiosynthesis of N-11C-methyl-taurine\u2013conjugated bile acids and biodistribution studies in pigs by PET\/CT","volume":"57","author":"Schacht","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nucmedbio.2018.04.004","article-title":"N-(4-[18F]fluorobenzyl)cholylglycine, a novel tracer for PETof enterohepatic circulation of bile acids: radiosynthesis and proof-of-concept studies in rats","volume":"2018","author":"Frisch","year":"2018","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.nucmedbio.2014.03.016","article-title":"Synthesis and evaluation of 18F-labeled bile acid compound: a potential PET imaging agent for FXR-related diseases","volume":"41","author":"Jia","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0110","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bmcl.2015.01.008","article-title":"Novel 64Cu-radiolabeled bile acid conjugates for targeted PET imaging","volume":"25","author":"Chong","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0115","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bmc.2016.12.008","article-title":"Design, synthesis, in vitro characterization and preliminary imaging studies on fluorinated bile acid derivatives as PET tracers to study hepatic transporters","volume":"25","author":"Testa","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173529","article-title":"Synthesis, in vitro and in vivo evaluation of 3\u03b2-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice","volume":"12","author":"Lombaerde","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.nucmedbio.2016.07.001","article-title":"Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function","volume":"43","author":"Neyt","year":"2016","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0130","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1021\/jm0310683","article-title":"Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging","volume":"47","author":"Anelli","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0135","first-page":"21","article-title":"Anatomic peculiarities of pig and human liver","volume":"15","author":"Nykonenko","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.trsl.2015.01.004","article-title":"Porcine models of digestive disease: the future of large animal translational research","volume":"166","author":"Gonzalez","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2967\/jnumed.117.196261","article-title":"RADAR dose estimate report: a compendium of radiopharmaceutical dose estimates based on OLINDA\/EXM version 2.0","volume":"59","author":"Stabin","year":"2018","journal-title":"J Nucl Med"},{"issue":"3\u20134","key":"10.1016\/j.nucmedbio.2019.07.006_bb0155","first-page":"5","volume":"32","year":"2002","journal-title":"Ann ICRP"},{"issue":"2\u20134","key":"10.1016\/j.nucmedbio.2019.07.006_bb0160","first-page":"1","article-title":"ICRP publication 103","volume":"37","author":"The 2007 Recommendations of the International Commission on Radiological Protection","year":"2007","journal-title":"Ann ICRP"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1113\/jphysiol.1990.sp017999","article-title":"Pyloric motor function during emptying of a liquid meal from the stomach in the conscious pig","volume":"422","author":"Treacy","year":"1990","journal-title":"J Physiol"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0170","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12149-013-0685-9","article-title":"Direct comparison of radiation dosimetry of six PET tracers using human whole-body imaging and murine biodistribution studies","volume":"27","author":"Sakata","year":"2013","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.apradiso.2013.01.014","article-title":"Biodistribution and radiation dosimetry of [18F]-5-fluorouracil","volume":"75","author":"Hino-Shishikura","year":"2013","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nucmedbio.2016.12.009","article-title":"A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor","volume":"47","author":"Petrulli","year":"2017","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.07.006_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40658-016-0160-5","article-title":"Radiation dosimetry of the \u03b14\u03b22 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET\/MRI and PET\/CT to first-in-human PET\/CT results","volume":"3","author":"Kranz","year":"2016","journal-title":"EJNMMI Physics"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805119300800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805119300800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:28:43Z","timestamp":1760848123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805119300800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":37,"alternative-id":["S0969805119300800"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2019.07.006","relation":{},"ISSN":["0969-8051"],"issn-type":[{"type":"print","value":"0969-8051"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C]cholylsarcosine","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2019.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}